NOAA's SOLAR‑1 is now operational and will deliver CME imagery to forecasters in about 30 minutes, sharpening aurora forecasts and giving operators more time to protect infrastructure.

Emory researchers report a targeted leukemia agent extended survival in mice and could cut the lifelong harms of pediatric chemotherapy.

Tempo is setting up its corporate headquarters in San Diego as it pushes to commercialize thermochemical “thermal battery” systems for industrial electrification. The move is meant to speed pilots into commercial deployments.

Phoenix centers are adding AI‑assisted mammograms and new intraoperative imaging, backed by a large U.S. study that showed higher detection rates. Surgeons say the tools can mean earlier treatment and fewer repeat procedures.

Planet Labs has expanded its SoMa manufacturing footprint and is ramping Pelican satellite production as government contracts and a new Berlin factory accelerate demand.

Elon Musk will speak virtually to ASML employees about his Terafab chip plan as SpaceX nears a blockbuster IPO. The closed-door talk puts ASML at the center of chip‑supply questions.

Sunshine Genetics will offer free, opt‑in whole‑genome sequencing to newborns at Tampa General this summer. The state pilot aims to detect hundreds of treatable genetic conditions earlier.

The Florida Supreme Court now requires signers to verify that cited authorities exist and are accurately cited. Jacksonville law programs and firms are adding verification steps.

CompTIA’s May data put Dallas‑Fort Worth third nationwide for tech job postings, with roughly 10,840 openings. Local training programs and employers are racing to close the talent gap.

Moffitt is piloting EMMA, an AI-driven lab platform that screens myeloma cells against 31 drugs to speed personalized treatment decisions.

Visa has embedded its payments network into ChatGPT, letting AI agents buy for users while banks and merchants raise fraud and fee questions. The shift moves agentic shopping from experiments toward network rails.

Federal prosecutors say LangInnov settled after allegedly performing SBIR‑funded R&D overseas, a possible breach of NSF rules. The U.S. Attorney’s office framed the move as enforcement of domestic R&D requirements.

UCHealth surgeons in Aurora have started offering the FDA‑approved TOUCH CMC 1 thumb implant, a European ball‑joint replacement that promises less pain and a quicker recovery. About 50 patients are already lined up.